| |
Women (n = 188)a
|
Men (n = 112)a
|
Low wealthb
|
High wealthb
|
|---|
|
PR (95% CI)
|
p
|
PR (95% CI)
|
p
|
PR (95% CI)
|
p
|
PR (95% CI)
|
p
|
|---|
|
Current NHIF coverage
|
1.61
|
(0.73, 3.53)
|
0.2
|
1.09
|
(0.26, 4.64)
|
0.9
|
1.60
|
(0.51, 4.97)
|
0.4
|
1.16
|
(0.42, 3.18)
|
0.8
|
|
Health screening outcomes
|
|
HIV screening
|
1.21
|
(1.08, 1.35)
|
0.007
|
1.26
|
(1.10, 1.44)
|
< 0.0001
|
1.32
|
(1.16, 1.51)
|
< 0.0001
|
1.11
|
(0.97, 1.25)
|
0.1
|
|
Diabetes screening
|
3.12
|
(2.16, 4.50)
|
< 0.0001
|
4.00
|
(2.74, 5.86)
|
< 0.0001
|
3.22
|
(2.17, 4.79)
|
< 0.0001
|
3.06
|
(2.06, 4.54)
|
< 0.0001
|
|
Hypertension screening
|
1.67
|
(1.40, 1.98)
|
< 0.0001
|
2.67
|
(2.02, 3.52)
|
< 0.0001
|
2.10
|
(1.68, 2.62)
|
< 0.0001
|
1.88
|
(1.52, 2.33)
|
< 0.0001
|
|
Tuberculosis screening
|
2.20
|
(1.02, 4.78)
|
0.02
|
12.23
|
(2.56, 58.46)
|
0.002
|
3.19
|
(1.24, 8.26)
|
0.02
|
3.63
|
(1.26, 10.43)
|
0.02
|
|
Cervical cancer screening
|
–
|
–
|
–
|
–
|
–
|
–
|
2.38
|
(0.93, 6.10)
|
0.07
|
2.35
|
(1.04, 5.30)
|
0.04
|
|
Disease management outcomes, among those diagnosed with HIV, diabetes, or hypertension (n = 32)
|
|
Medical visit in last 6 months
|
1.67
|
(0.98, 2.82)
|
0.06
|
1.20
|
(0.84, 1.72)
|
0.3
|
1.37
|
(0.82, 2.31)
|
0.2
|
1.40
|
(0.57, 3.42)
|
0.6
|
|
Currently taking medication
|
1.94
|
(0.95, 3.96)
|
0.07
|
1.00
|
(0.20, 4.95)
|
1.0
|
1.65
|
(0.77, 3.53)
|
0.2
|
1.17
|
(0.23, 5.95)
|
0.9
|
- aWald p-values for interaction terms between gender and microfinance group membership were < 0.05 for the tuberculosis screening outcome only
- bWald p-values for interaction terms between gender and household wealth asset (dichotomized at median) were < 0.05 for the HIV screening outcome only
